Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
AMEXInformation TechnologyCommunication EquipmentSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.22 → 4.22 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BKTI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve EPS of at least $3.55 in fiscal 2026 | A primary condition in BK Technologies Corp.'s published investment case. The stated target is >= $3.55 per share. | Intact | EPS falls below $3.20 in FY26 | Diluted EPS: $0.79 per share FY2026-Q2; GAAP. Published target: >= $3.55 per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20260.79 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a smaller-cap growth and product-execution story, with elevated risk and recent earnings surprises that have been erratic. The long-term thesis is intact, supported by recent financial performance that remains in the top half of its industry.
The valuation evidence says BKTI is cheap versus peers, while the expectations gap is negative, suggesting expectations are not especially demanding. Valuation has risen recently, but priced-in fragility is rated low and the overall setup is classified as justified.
Near term, management’s goals look on track: first-half revenue grew 11.2%, gross margin reached 51.8%, and the 2026 revenue and margin goals were reiterated. The BKR9500 radio remains on schedule for approval in the second half of 2026 and customer deliveries in the first half of 2027, while erratic earnings and smaller-cap risk leave some chance of a miss.
The main company-specific swing factor is whether BKTI maintains guidance and delivers on its 2026 revenue and margin goals; a guidance cut would weaken the thesis. The launch schedule also matters over the next year, while lower interest rates and steadier results from large technology peers could improve the sector backdrop.
Over the next 1 to 3 years, the thesis rests on continued execution in revenue, margins, and the BKR9500 launch, with elevated risk and a fragile near-term outlook for guidance. Recent performance supports an intact multi-year view, but the evidence is only medium confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 2 supplied quarters. Management reported: “These targets reflect expensing of engineering costs that were previously capitalized.” “Gross margin of 51.9% expanded by 445 basis points compared to 47.4% in the second quarter of 2025, primarily related to favorable product mix and continued customer adoption of the BKR 9000 handheld multiband radio.” Gross profit was $12.143 million in 2026-Q2.
Obtain FCC approval for BKR 9500 product in H2 2026 | FCC approval for new products could boost sales. | Intact | FCC approval delayed beyond 2026 | FCC approval targeted for H2 2026 (on track) Q2 2026 earnings call confirms BKR 9500 targets FCC approval in H2 2026; deliveries targeted for H1 2027. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain gross margin at or above 50% in fiscal 2026 | BK Technologies aims for $90M revenue and 50% gross margin in 2026. | Intact | gross margin falls below 45% in FY26 | Gross margin: 51.86% FY2026-Q2; GAAP. Published target: >= 50%. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 202651.862134 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “These targets reflect expensing of engineering costs that were previously capitalized.” “Gross margin of 51.9% expanded by 445 basis points compared to 47.4% in the second quarter of 2025, primarily related to favorable product mix and continued customer adoption of the BKR 9000 handheld multiband radio.” Gross profit was $12.143 million in 2026-Q2. Delivery assessment Nov 5, 2026 |
Achieve at least $90M revenue in fiscal 2026 | A primary condition in BK Technologies Corp.'s published investment case. The stated target is >= $90 million. | Intact | annual revenue falls below $80 million in FY26 | Revenue: $23.414M FY2026-Q2; GAAP. Published target: >= $90 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 202623,414,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.22 → $4.22 · observed estimates
$0.10B → $0.10B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-25 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-26 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-27 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-28 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-29 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-30 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-07-31 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-01 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-02 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-03 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-04 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-05 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-06 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-07 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-08 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-09 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-10 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-11 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-12 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-13 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-14 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-15 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-16 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-17 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-18 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-19 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-20 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-21 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-22 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-23 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-24 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-25 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-26 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-27 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-28 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-29 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-30 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-08-31 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-01 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-02 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-03 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-04 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-05 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-06 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-07 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-08 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-09 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-10 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-11 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-12 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-13 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-14 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-15 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-16 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-17 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-18 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-19 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-20 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-21 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-22 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-23 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-24 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-25 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-26 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-27 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-28 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-29 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-09-30 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-01 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-02 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-03 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-04 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-05 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-06 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-07 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-08 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-09 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-10 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-11 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-12 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-13 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-14 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-15 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-16 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-17 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-18 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-19 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-20 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-21 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-22 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-23 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-24 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-25 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-26 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-27 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-28 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-29 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-30 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-10-31 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-11-01 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-11-02 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-11-03 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-11-04 | $4.22 | $103,500,000 | 1 / 1 |
| 2026-11-05 | $4.22 | $103,500,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.